BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3754587)

  • 1. Blood-CSF barrier to CCK and effect of centrally administered bombesin on release of brain CCK.
    Zhu XG; Greeley GH; Lewis BG; Lilja P; Thompson JC
    J Neurosci Res; 1986; 15(3):393-403. PubMed ID: 3754587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cholecystokinin in feeding and lactation.
    Lindén A
    Acta Physiol Scand Suppl; 1989; 585():i-vii, 1-49. PubMed ID: 2603747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central versus peripheral effects of bombesin on the release of gastrointestinal hormones in dogs.
    Lu QH; Swierczek JS; Zhu XG; Greeley GH; Thompson JC
    J Neurosci Res; 1986; 16(3):553-9. PubMed ID: 3772992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atropine, proglumide, and somatostatin analogue (SMS 201-995) on bombesin-induced gallbladder contraction and CCK secretion in humans.
    Mitsukawa T; Takemura J; Nishizono F; Nakatsuru K; Ohgo S; Matsukura S
    Am J Gastroenterol; 1989 Nov; 84(11):1371-4. PubMed ID: 2683738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of different anesthetic agents on the release of cholecystokinin in dogs.
    Lilja P; Wiener I; Inoue K; Priano LL; Greeley GH; Thompson JC
    Surgery; 1985 Apr; 97(4):415-9. PubMed ID: 3983816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing central and peripheral actions of brain-gut peptides: a basis for regulation of gastric function.
    Pappas TN; Taché Y; Debas HT
    Surgery; 1985 Aug; 98(2):183-90. PubMed ID: 2862711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a cholecystokinin gut-brain axis with modulation by bombesin.
    Banks WA
    Peptides; 1980; 1(4):347-51. PubMed ID: 7301638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bombesin on plasma cholecystokinin in normal persons and gastrectomized patients measured by sequence-specific radioimmunoassays.
    Jansen JB; Lamers CB
    Surgery; 1984 Jul; 96(1):55-60. PubMed ID: 6740496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-Delta 2-valproic acid in rabbits.
    Scism JL; Powers KM; Artru AA; Chambers AC; Lewis L; Adkison KK; Kalhorn TF; Shen DD
    Drug Metab Dispos; 1997 Dec; 25(12):1337-46. PubMed ID: 9394022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of cholecystokinin-33 in vivo: effect of L-364,718, a CCK receptor antagonist.
    Hosotani R; Doi R; Gu Y; Wada M; Inoue K; Fujii N; Rayford PL; Imamura M
    Ann Clin Lab Sci; 1994; 24(4):346-54. PubMed ID: 7944271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cadmium and bombesin on exocrine pancreatic secretions and plasma levels of gastrin and cholecystokinin (CCK) in rats.
    Chowdhury P; Ami M; Rayford PL
    Ann Clin Lab Sci; 1986; 16(6):479-87. PubMed ID: 3800302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intraduodenal bile salt on pancreaticobiliary responses to bombesin and to cholecystokinin in humans.
    Thimister PW; Hopman WP; Tangerman A; Rosenbusch G; Willems HL; Jansen JB
    Hepatology; 1998 Dec; 28(6):1454-60. PubMed ID: 9828206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic stimulation of pancreatic polypeptide release by a meal, bombesin, neurotensin, tetragastrin, cholecystokinin, and cerulein.
    Modlin IM; Jaffe BM; Albert D; Sank A; Materia A; Crochelt R
    J Surg Res; 1983 Aug; 35(2):113-8. PubMed ID: 6310229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-2 and blood brain barrier in cats: pharmacokinetics and tolerance following intrathecal and intravenous administration.
    Martin R; Schwuléra U; Menke G; Rudolph W; Buch K; Fasold H; Lissner R; Thrun A; Krauseneck P; Bogdahn U
    Eur Cytokine Netw; 1992; 3(4):399-406. PubMed ID: 1421012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-gut axis in gastroprotection by leptin and cholecystokinin against ischemia-reperfusion induced gastric lesions.
    Brzozowski T; Konturek PC; Pajdo R; Kwiecień S; Ptak A; Sliwowski Z; Drozdowicz D; Pawlik M; Konturek SJ; Hahn EG
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):583-602. PubMed ID: 11787760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of intestinal cholecystokinin and somatostatin mRNA by bombesin in rats.
    Kanayama S; Liddle RA
    Am J Physiol; 1991 Jul; 261(1 Pt 1):G71-7. PubMed ID: 1677536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue and plasma levels of immunoreactive gastrin and cholecystokinin in chickens with and without bombesin.
    Rayford PL; Inoue K; Chowdhury P; McKay D
    J Assoc Acad Minor Phys; 1991; 2(2):67-71. PubMed ID: 1810583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of CCK and bombesin on ACTH and cortisol secretion in the conscious dog.
    Thomas RM; Sander LD
    Peptides; 1985; 6(4):703-7. PubMed ID: 2999733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atropine inhibits meal-stimulated release of cholecystokinin.
    Maton PN; Selden AC; Chadwick VS
    Scand J Gastroenterol; 1984 Sep; 19(6):831-4. PubMed ID: 6096959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats: intravenous infusion studies.
    Anderson BD; Hoesterey BL; Baker DC; Galinsky RE
    J Pharmacol Exp Ther; 1990 Apr; 253(1):113-8. PubMed ID: 2109797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.